Resources gathered from OPA's collaboration with stakeholders including the Ministry of Health's Emergency Operations Centre, Public Health Ontario, Public Health Agency of Canada, International Pharmaceutical Federation and other sources that are helpful in navigating COVID-19.
The Canadian Pharmacists Association (CPhA) has put together a collection of resources on pharmacy practice, awareness, advocacy, mental health and wellness, drug information, patient information and answers to day to day COVID-19 questions for front-line pharmacy workers.
The CSHP provides special open access to the Pharmacy Specialty Network (PSN) to share information and best hospital pharmacy practices regarding COVID-19. There is also information on advocacy, insurance and other tools & resources.
The Pharmacists' Guide to COVID-19 contains practice resources for pharmacists, CDC Guidance for Pharmacies, NIH COVID-19 Treatment Guidelines, and APhA curated key literature.
FIP provides clinical information, treatment guidelines, pharmacy workforce guidelines, guidance summaries, FAQ and mythbusting, and collected resources from organizations around the world
The ECDC provides risk assessments, public health guidance and advice on response activities have been provided by the agency. Situation updates, including information on the epidemiological curve and the global distribution, are made available daily.
Get access to the special editions of the ISMP Medication Safety Alert! Acute Care newsletter that focus only on COVID-19 safety issues and insights along with access to other resources, articles, and webinars.
The Government of Canada's guide contains information health professionals need to know on COVID-19 topics such as transmission, epidemiology, detecting and reporting, infection control and prevention, treatment and guidance.
Health Canada has issued the attached exemptions for prescriptions of controlled substances under the Controlled Drugs and Substances Act (CDSA) and its Regulations.
This document from the British Columbia Centre on Substance Use (BCCSU) outlines guidance for prescribing opioid agonist treatment during the COVID-19 pandemic.
